Pharmaceutical E-Commerce Sector Drops 0.26%; Hengrui Medicine Tops Net Inflow
The pharmaceutical e-commerce concept sector fell 0.26% at the August 5 close, with main capital net outflow of RMB 374 million. Huadong Medicine saw the largest outflow at RMB 88.16 million, while Hengrui Medicine led inflows with RMB 127 million. Among 49 advancing stocks, Aidi Pharmaceutical rose 10.73%, Yingnuote gained 7.73%, and ST Xiangxue added 6.76%.
As of the close on August 5, the pharmaceutical e-commerce concept sector declined 0.26% overall. Within the sector, stocks including Chongqing Pharmaceutical Holding, Jointown Pharmaceutical Group, and Tianyu posted the largest declines, while 49 stocks advanced, led by Aidi Pharmaceutical up 10.73%, Yingnuote up 7.73%, and ST Xiangxue up 6.76%.
In terms of capital flows, the sector recorded a main capital net outflow of RMB 374 million on the day, with 118 stocks seeing net outflows, of which 24 exceeded RMB 10 million. Huadong Medicine posted the largest net outflow at RMB 88.16 million, followed by Harbin Pharmaceutical at RMB 67.19 million, Yiling Pharmaceutical at RMB 34.25 million, and Kangmei Pharmaceutical at RMB 32.82 million.
On the net inflow side, Hengrui Medicine led with RMB 127 million, followed by Zhongsheng Pharmaceutical with RMB 57.56 million and BGI with RMB 31.08 million.